Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,563 Cr
down ₹224 Cr vs Nov 2022
- Stocks held
- 31
- unchanged
- Top 10 weight
- 66.1%
- of the portfolio in its ten largest
- Cash & debt
- 0.4%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 7, trimmed 22
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In December 2022 it disclosed 31 stocks worth ₹4,563 Cr, down ₹224 Cr from Nov 2022. Its largest positions were Sun Pharmaceutical Industries Limited (14.4%), Dr. Reddy's Laboratories Limited (8.2%), Cipla Limited (8.0%); the ten largest together made up 66.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 78.0% of its equity. Cash and debt stood at 0.4%. Compared with Nov 2022 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
92%
Top-10 weight is higher than 92% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
6%
Holds more cash than 6% of peers
Holdings in December 2022
Download CSVEvery line the fund disclosed, with the change against Nov 2022. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.39%
- Δ weight
- down 0.91 pts
- Value
- ₹657 Cr
- Δ value
- down ₹75.8 Cr
- Status
- Trimmed
- Weight
- 8.22%
- Δ weight
- down 0.08 pts
- Value
- ₹375 Cr
- Δ value
- down ₹22.1 Cr
- Status
- Trimmed
- Weight
- 8.02%
- Δ weight
- down 0.79 pts
- Value
- ₹366 Cr
- Δ value
- down ₹55.8 Cr
- Status
- Trimmed
- Weight
- 7.24%
- Δ weight
- up 0.03 pts
- Value
- ₹330 Cr
- Δ value
- down ₹14.6 Cr
- Status
- Trimmed
- Weight
- 6.06%
- Δ weight
- up 0.59 pts
- Value
- ₹276 Cr
- Δ value
- up ₹14.6 Cr
- Status
- Added
- Weight
- 5.11%
- Δ weight
- down 0.03 pts
- Value
- ₹233 Cr
- Δ value
- down ₹13 Cr
- Status
- Trimmed
- Weight
- 4.97%
- Δ weight
- up 0.34 pts
- Value
- ₹227 Cr
- Δ value
- up ₹5.3 Cr
- Status
- Added
- Weight
- 4.86%
- Δ weight
- up 0.24 pts
- Value
- ₹222 Cr
- Δ value
- up ₹55 L
- Status
- Held
- Weight
- 3.74%
- Δ weight
- down 0.77 pts
- Value
- ₹171 Cr
- Δ value
- down ₹45.2 Cr
- Status
- Trimmed
- Weight
- 3.51%
- Δ weight
- up 0.12 pts
- Value
- ₹160 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 3.36%
- Δ weight
- down 0.06 pts
- Value
- ₹153 Cr
- Δ value
- down ₹10.2 Cr
- Status
- Trimmed
- Weight
- 3.23%
- Δ weight
- up 0.03 pts
- Value
- ₹148 Cr
- Δ value
- down ₹5.6 Cr
- Status
- Trimmed
- Weight
- 3.18%
- Δ weight
- up 0.22 pts
- Value
- ₹145 Cr
- Δ value
- up ₹3.5 Cr
- Status
- Added
- Weight
- 2.85%
- Δ weight
- up 0.20 pts
- Value
- ₹130 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 2.85%
- Δ weight
- up 0.03 pts
- Value
- ₹130 Cr
- Δ value
- down ₹4.9 Cr
- Status
- Trimmed
- Weight
- 2.67%
- Δ weight
- up 0.82 pts
- Value
- ₹122 Cr
- Δ value
- up ₹33.5 Cr
- Status
- Added
- Weight
- 2.50%
- Δ weight
- down 0.22 pts
- Value
- ₹114 Cr
- Δ value
- down ₹16 Cr
- Status
- Trimmed
- Weight
- 2.39%
- Δ weight
- up 0.07 pts
- Value
- ₹109 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 2.07%
- Δ weight
- down 0.16 pts
- Value
- ₹94.6 Cr
- Δ value
- down ₹12.2 Cr
- Status
- Trimmed
- Weight
- 1.86%
- Δ weight
- up 0.02 pts
- Value
- ₹84.9 Cr
- Δ value
- down ₹3.4 Cr
- Status
- Trimmed
- Weight
- 1.64%
- Δ weight
- up 0.11 pts
- Value
- ₹74.6 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Weight
- 1.29%
- Δ weight
- up 0.02 pts
- Value
- ₹59.1 Cr
- Δ value
- down ₹1.7 Cr
- Status
- Trimmed
- Weight
- 0.80%
- Δ weight
- down 0.03 pts
- Value
- ₹36.4 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 0.52%
- Δ weight
- up 0.02 pts
- Value
- ₹23.7 Cr
- Δ value
- down ₹33 L
- Status
- Trimmed
- Weight
- 0.45%
- Δ weight
- up <0.01 pts
- Value
- ₹20.6 Cr
- Δ value
- down ₹92 L
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.45%
- Δ weight
- up 0.09 pts
- Value
- ₹20.4 Cr
- Δ value
- up ₹3.4 Cr
- Status
- Added
- Weight
- 0.38%
- Δ weight
- up 0.23 pts
- Value
- ₹17.2 Cr
- Δ value
- up ₹10.3 Cr
- Status
- Added
- Weight
- 0.38%
- Δ weight
- up 0.01 pts
- Value
- ₹17.1 Cr
- Δ value
- down ₹15 L
- Status
- Trimmed
- Weight
- 0.34%
- Δ weight
- up 0.01 pts
- Value
- ₹15.4 Cr
- Δ value
- down ₹5 L
- Status
- Held
- Weight
- 0.25%
- Δ weight
- up <0.01 pts
- Value
- ₹11.5 Cr
- Δ value
- down ₹34 L
- Status
- Trimmed
- Weight
- 0.23%
- Δ weight
- up <0.01 pts
- Value
- ₹10.5 Cr
- Δ value
- down ₹40 L
- Status
- Trimmed
- Weight
- 0.21%
- Δ weight
- down 0.18 pts
- Value
- ₹9.5 Cr
- Δ value
- down ₹9.1 Cr
- Status
- Trimmed
What changed, Nov 2022 to Dec 2022
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Ajanta Pharma Limitedup ₹33.5 Cr (+0.82% pts)
- Abbott India Limitedup ₹14.6 Cr (+0.59% pts)
- MedPlus Health Services Limitedup ₹10.3 Cr (+0.23% pts)
- Narayana Hrudayalaya Limitedup ₹5.3 Cr (+0.34% pts)
- Zydus Lifesciences Limitedup ₹3.5 Cr (+0.22% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2022, the weight rose most in Retailing (+0.2 pts) and Healthcare Services (+0.1 pts), and fell most in Pharmaceuticals & Biotechnology (−0.5 pts).
- Retailing0.1% → 0.4%+0.2 pts
- Healthcare Services19.5% → 19.6%+0.1 pts
- Pharmaceuticals1.5% → 1.6%+0.1 pts
- Pharmaceuticals & Biotechnology78.5% → 78.0%−0.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2019 | Dec 2021 | Jun 2022 | Sep 2022 | Nov 2022 | Dec 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.2% | 76.5% | 80.3% | 80.0% | 78.5% | 78.0% |
| Healthcare Services | 20.4% | 21.0% | 17.4% | 18.3% | 19.5% | 19.6% |
| Pharmaceuticals | 1.4% | 2.0% | 1.7% | 1.3% | 1.5% | 1.6% |
| Retailing | — | — | — | — | 0.1% | 0.4% |
| Healthcare Equipment & Supplies | — | 0.5% | 0.6% | 0.4% | 0.3% | 0.3% |
Allocation in Dec 2022change vs Nov 2022
- Pharmaceuticals & Biotechnology (19)78.0%▼ 0.5 pts
- Healthcare Services (9)19.6%▲ 0.1 pts
- Pharmaceuticals (1)1.6%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Dec 2022
0.4%
▲ 0.1 pts vs Nov 2022
- Cash alone
- 0.4%
- cash and net receivables
- A year earlier
- 0.9%
- Dec 2021 · now ▼ 0.4 pts
- Last 12 months
- 0.3% – 2.2%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.